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Purpose: To evaluate whether mouse adipose tissue mesothelial cells (ATMCs) share 
morphological and biochemical characteristics with mouse corneal endothelial cells 
(MCECs) and to evaluate their capacity to adhere onto the decellularized basal membrane 
of human anterior lens capsules (HALCs) as a potential tissue engineered surrogate for 
corneal endothelium replacement. Methods: ATMCs were isolated from the visceral 
adipose tissue of adult mice and their expression of several corneal endothelium markers 
was determined with qRT-PCR and immunofluorescence. ATMCs were shortly cultured in 
a Mesothelial Retaining Phenotype Media (MRPM) and further seeded and cultured on top 
of the decellularized basal membrane of HALCs. ATMCs-HALCs composites were 
evaluated by optical microscopy, immunofluorescence and transmission electron 
microscopy. Results: Freshly isolated and MRPM cultured ATMCs expressed the corneal 
endothelium markers COL4A2, C0L8A2, SLC4A4, CAR2, Na+/K+-ATPase, β-catenin, Zona 
Occludens-1 and N-cadherin at both the mRNA and protein levels. Furthermore, ATMCs 
displayed strong adhesion capacity onto the basal membrane of HALCs and formed a 
confluent monolayer within 72 hours of culture in MRPM. Ultrastructural morphological and 
marker characteristics displayed by ATMCs monolayer onto HALCs clearly indicate that 
ATMCs retained their original phenotype of squamous epithelial-like cells. Conclusions: 
MCECs and ATMCs share morphological and markers similarities. ATMCs adhered and 
formed structures mimicking focal adhesion complexes with the HALCs basal membrane. 
Monolayer structure and achieved density of ATMCs support the proposal of using adult 







 Tissue engineering is a complex interdisciplinary field gathering principles and 
methods of bioengineering, material science, and life sciences aimed to build biological 
surrogates which may be able to substitute for the native tissue functions lost after disease 
or traumatic processes1-3. The election of a suitable cellular phenotype displaying the 
functions of the damaged cells in combination with the use of an adequate biological 
support or scaffold mimicking finely the biophysical properties of the tissue (i.e matrix 
protein composition and stiffness) are two major parameters that need to be carefully 
determined to engineer successful tissues biomimetics and ensure their long-term patency 
after transplantation. 
 The cornea is an extraordinary example of fine natural engineering, with its 
sophisticated disposition of collagen lamellaes and cells with the lack of blood vessels in 
order to shape a total clear lens4. In this disposition, the corneal endothelium with its single 
layer of flat hexagonal cells attached firmly to the Descemet´s membrane play an 
important role in regulating the state of corneal stromal hydration by a Na+/K+-ATPase 
endothelial pump and focal tight junctions that allows permeability to nutrients and other 
molecules from the aqueous humor. Furthermore, corneal endothelial cells (CECs) are 
metabolically very active, with large numbers of mitochondria to provide the high amount 
of energy required to pump water efficiently4. 
Cumulative evidence suggests that the postnatal corneal endothelium lacks 
regenerative capacities and compensates its gradual loss of cellularity along life through 
hypertrophy of preexisting cells4-6. A critical loss of corneal endothelium cellularity caused 
either by accidents, surgical trauma or diseases may no longer ensure a proper regulation 
of stromal hydration, leading to severe corneal swelling, loss of stromal transparency and 
severe visual impairment. The only effective treatment so far is corneal transplantation to 
restore normal vision. Descemet stripping automated endothelial keratoplasty (DSAEK) 
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allows a selective substitution of the damaged corneal endothelium achieving very good 
results7, 8. Unfortunately, the development of DSAEK is largely constrained by the limited 
availability of donor corneas.  
Several studies have reported the tissue engineering of corneal endothelium 
biosubstitutes as an alternative issue to a corneal transplantation: Cultured HCECs 
transplanted onto chitosan-based membranes 9, 10, Descemet´s membrane11-21, collagen 
matrix22, human corneal stromal discs23, 24, gelatin hydrogel discs25, 26, acellular porcine 
corneal matrix27, pericellular matrix prepared from human decidua-derived mesenchymal 
cells28 and plastic compressed collagen29. Alternatively, the lack of source of HCECs and 
their limited proliferation capacity in vitro also led to several researchers to evaluate the 
generation in vitro of CEC-like cells from distinct cell types such as embryonic neural crest 
cells10, corneal stroma stem cells30, umbilical cord blood mesenchymal stem cells31 or 
human ESCs32. Despite these interesting results highlighting the different potential of 
these stem cells in regeneration of the corneal endothelium, their clinical application is 
however facing different problems related to immune rejection, ethic or limited tissue 
accessibility. The need to overcome these limitations will imply further efforts to identify 
novel sources of autologous cells that are phenotypically and functionally as close as 
possible to native CECs and that should be in addition, preferentially isolated from a 
source that is extraocular, abundant and clinically accessible. 
The mesothelium is the outermost tissue layer lining the parietal surface of coelomic 
cavities (pleural, pericardial and peritoneal) and the visceral organs where they are 
housed33. It was first described by Bichat in 1827 as a tissue displaying features of simple 
squamous epithelium34. Although mesothelial cells (MCs) originate from the embryonic 
mesoderm33, 35, they rather display morphological and biochemical characteristics 
consistent with simple squamous epithelial cells33, 36. Among their main biological functions 
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described so far is to secrete glycosaminoglycans and lubricants to provide a protective 
and slippery surface for the optimal sliding of visceral organs inside coelomic cavities, 
such as the beating heart or the expanding lungs31, 36-38. In addition, MCs also play a 
central role in a variety of intraserosal and submesothelial processes, including the 
transport of water and solutes, inflammation, host response, angiogenesis, tissue repair, 
and extracellular matrix remodeling31, 36-40. 
A careful examination and comparison of the morphological and biochemical 
hallmarks specific to the mesothelium and corneal endothelium leads to the conclusion 
that both tissues share many similarities. Hence, they are both composed of a single 
monolayer of flattened cells tightly compacted together and that is anchored onto a 
basement membrane that functions as a scaffold to keep orderly tissue structures4, 37, 41. 
Developmentally, the corneal endothelium is derived from the cranial neural crest42, 43. In 
contrast to vascular endothelial cells, HCECs lack significant expression of the vascular 
ECs markers von Willebrand Factor (Factor VIII) and CD3144, 45. Phenotypically, HCECs 
rather resemble to human MCs, and as such, both cell types constitutively express 
cytokeratin 1846, an intermediate filament that is however absent in vascular endothelial 
cells47. Furthermore, HCECs also express significant levels of the mesothelial proteins 
HBME1, mesothelin and calbindin 248. Functionally, the corneal endothelium and 
mesothelium are both semi-permeable membranes involved in electrolytes and water 
transport, mechanisms which are mainly mediated through their significant Na+/K+-ATPase 
pump activity4, 49, 50. Taken in account these findings, we hypothesized that MCs may 
represent a valuable cellular surrogate of CECs and should serve to build corneal 
endothelium biomimetics. 
Unpublished results from CABIMER and NewBiotechnic researchers indicate that 
mouse adipose tissue MCs (ATMCs) can attach to different biomaterials, retaining both the 
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capability to proliferate in a monolayer until they fit the whole area. Once attained a full 
coverage, ATMCs display contact inhibition of proliferation. Working on this basis, we 
hypothesized that the adult mesothelium should represent a valuable source with capacity 
to substitute structurally and biochemically the damaged corneal endothelium. In this 
study, we devised a methodology to achieve a full mesothelialization of the decellularized 
basal membrane of human anterior lens capsules using mouse ATMCs. 
Material and Methods 
Isolation of mouse ATMCs 
ATMCs were isolated from CD1 adult female mice. Guidelines for the animal 
research protocols were established and approved by the Animal Experimentation and 
Ethics Committee of CABIMER. Briefly, uterine cords and adipose tissue were surgically 
separated. Enzymatic detachment of ATMCs from fat pads was performed with minor 
modifications as previously reported for the isolation of mouse uterine MCs51.  
Culture of ATMCs 
ATMCs were seeded (35000 cells/cm2) into T-25 flask (136196, Nunc) into 5 ml of a 
Mesothelial Retaining Phenotype Media (MRPM) consisting of a DMEM low glucose 
GlutaMax media (21885-05, Gibco) supplemented with 2% FBS (Lonza), 1% B27 
supplements (17504, Gibco), 1% penicillin-streptomycin (Gibco), 100 µM β-
mercaptoethanol (31350-010, Gibco) and 1 µg/ml of hydrocortisone (Sigma Aldrich). 
ATMCs were cultured for 2 days in MRPM (5% CO2, 21% O2 and 37ºC) and harvested 
with trypsin (15400-054, Gibco).  
Murine corneal endothelial cells culture  
Primary murine corneal endothelial cells (MCECs) were isolated by collecting 
corneas from two to three adult CD1 mice (2-6 months old). Corneal endothelium layer 
was gently stripped off with the help of a scalpel. MCECs clusters released through 
stripping were then subjected to primary explant culture during 7 days in an incubator (5% 
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CO2, 21% O2, 37ºC) in a medium consisting of a DMEM low glucose GlutaMax media 
(21885-05, Gibco) containing 5% FBS (Lonza), 1% penicillin-streptomycin (Gibco), 1% 
non-essential amino acids (Gibco), 100 µM β-mercaptoethanol (31350-010, Gibco), 1X 
ITS (41400045, Gibco), 10 ng/ml recombinant murine bFGF (450-33, PeproTech), 10 
ng/ml recombinant murine EGF (315-09, PeproTech) and 1 µg/ml hydrocortisone (Sigma 
Aldrich). Primary expanded MCECs were further subcultured three times at 5000 cells/cm2 
during 4-5 days into T-75 flasks (156499, Nunc). MCECs in subculture passage 3 used in 
the study were termed P3 MCECs. 
Immunofluorescence 
For immunofluorescence, cells were cultured into µ-Dish (45079, Ibidi GmbH, 
Germany). For cell-surface antigens detection, cells were fixed with 4% PFA (P6148, 
Sigma Aldrich) and blocked in PBS containing 3% BSA (PBS-BSA). For intracellular 
antigens detection, cells were permeabilized with 0.5 % Triton X-100 (Sigma, T8787) or 
cold methanol (-20ºC) and then blocked into PBS-BSA. Antibodies used in this study are 
described in supporting information Table S1. Nuclei were counterstained with 1 μg/ml 
Hoechst 33342 (Sigma, 14533). Fluorescence images were captured with an inverted 
fluorescence microscope Olympus IX71 (Olympus. www.olympus.co.uk).  
Quantitative reverse Transcription-Polymerase Chain Reaction 
Total RNA content was extracted with RNeasy Mini Kit (74104, QIAGEN), and 
reverse-transcribed into cDNA by using MMLV reverse transcriptase (Promega, Madison, 
WI, USA)). Quantitative real-time PCR was performed using SYBR-Green and detected 
using an ABI Prism 7500 system (Applied Biosystems, Foster City, CA, USA). Gene 
expression was normalized to HYWAZ mRNA (TATAA Reference Gene Panel, ref. D101-
D136, TATAA Biocenter AB, Göteborg, Sweden). Stripped corneal endothelium served as 
the calibrator sample. Primers sequences are in listed in supporting information Table S2. 
Human anterior lens capsules 
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Adjustment of HALCs 
A total of 34 human anterior lens capsules (HALCs) of 5 mm diameter were 
obtained after patient informed consent during normal cataract surgery procedures. 
HALCs were directly stored in distilled water to accomplish a total decellularized basal 
membrane. To note, HALCs were invariantly rolled or folded due to their natural convex 
structure, being their inner side corresponding to the decellularized epithelial side. HALCs 
were further distributed into 35 mm cell culture dishes vented with 4 inner rings (627170, 
Greiner CELLSTAR®) into 100 μl of distilled water. HALCs were correctly oriented with 
their outer side facing plastic surface. Their complete flattening was achieved by 
eliminating gradually water with the use of a pipette and needles.  
Seeding of HALCs with ATMCs 
An initial volume of 60µl MRPM containing 105 ATMCs was dropped onto HALCs. 
Culture dishes containing the seeded HALCs were then placed in a 140 mm Petri dish 
containing pieces of tissue paper soaked in water to maintain optimal humidification and 
were finally transferred in an incubator (5% CO2, 21% O2, 37ºC). Around 80-90% of ATMCs 
were already firmly adhered after 2 hours of culture. An additional volume of 120 µl of 
MRPM was then carefully added to the rings. After 6 hours, a final volume of 1.2 ml of 
MRPM was carefully added out of the rings. After 24 and 48 hours, MRPM (1.5 ml) was 
exchanged. After 72 hours, HALCs typically displayed complete cellular coverage and 
termed ATMCs-HALCs composites.  
Transmission electronic microscope 
ATMCs-HALCs composites (n=8) were fixed with 1.6% glutaraldehyde in 0.15M 
sodium cacodylated buffer (pH 7.3) for 1 hour at 4ºC. HALCs were then post fixed in 1% 
OsO4 in the same buffer, dehydrated in ethanol and embedded in epoxy resin. Thin 
sections were cut and stained with uranyl acetate and lead citrate to be examined with a 
PHILIPS CM-10 transmission electron microscope operating at 80 kV. The electron 
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microscopy data were collected after identification of transversal cuts of ATMCs-HALCs 
composites at primary magnification 5,000x and pictures were taken at enlargements of 
20,000x. 
Immunohistochemistry  
Mouse corneas from CD1  adult mice were fixed with 4% PFA, permeabilized and 
blocked into PBS-Tx-BSA and finally embedded in OCT cryostat sectioning medium. 
Alternatively, corneas were fixed and permeabilized in cold methanol for Na+/K+-ATPase 
and β-catenin detection. Thin sections (15 μm) were mounted onto poly-L-lysine coated 
glass slides and incubated with primary and secondary antibodies (supporting information 
Table S1). 
MetaMorph-based quantification of cellularity 
The cellularity of ATMCs-HALCs composites was quantified with Meta Imaging 
Software MetaMorph Offline version 7.5.1.0 (MDS Analytical technologies, Sunnyvale, CA, 
USA). Squares areas of 40 000 μm2 (n= 12) were extracted from phase contrast pictures 
of ATMCs lining HALCs and numbers of cells in each square were calculated with 
“manually count objects” function. For cell density quantification of the adult mouse corneal 
endothelium, intact corneas were fixed with PFA and stained with Hoechst 33342 before 
being mounted in sandwich between thin glass coverslips. Fluorescence pictures of the 
corneal endothelium layer were taken. Numbers of cells in squares areas of 40 000 μm2 
were determined by calculating numbers of nuclei. Mean numbers of cells in squares were 
used to deduce the mean ± SD number of cells/mm2. 
Statistical analysis 
Values are presented as mean ± SD. Statistical significance was calculated by using an 






Characterization of ATMCs cultured in MRPM 
A gentle trypsinization of the adipose tissue could efficiently and selectively release 
its outermost MCs layer (Fig. 1A). Adipose tissue MCs (ATMCs) cultured for 48 hours in 
MRPM typically generated a cobblestone-like monolayer of flattened polygonal epitheloid 
cells (Fig. 1B). Consistent with their mesothelial phenotype, the MRPM cultured ATMCs 
displayed typical intercellular expression of β-catenin and zona occludens-1 (ZO-1). 
Furthermore, they also displayed wide nuclear expression of Wilm´s Tumor Protein (WT1) 
and membrane expression of mesothelin (data not shown). The MRPM cultured ATMCs 
lacked detectable expression of the pan-endothelial cells marker CD31. Furthermore, and 
consistent with their mesothelial nature, the MRPM cultured ATMCs did not exhibited 
stress fibers positive for F-actin and α-SMA. Finally, ATMCs culture displayed some nuclei 
Ki-67 positive, indicating that a pool of ATMCs was proliferating. 
Isolation and characterization of mouse CECs 
Our stripping procedure typically resulted in the detachment of large clusters of the 
corneal endothelium layer from the Descemet´s membrane (Fig. 2A and 2B). 
Immunofluorescence analysis of fragments of stripped Descemet´s membrane could 
confirm that they were mainly devoid of their corneal endothelium layer (Supplementary 
Fig. S1). Clusters of MCECs subjected to explant culture could successfully adhere, 
spread and proliferate to form a compact monolayer with cobblestone morphology within 
5-7 days of culture (Fig. 2C). The establishment of highly homogeneous cultures of 
polygonal MCECs could be achieved through sequential subculture of MCECs until 
passage 3 (P3 MCECs) (Fig. 2D-F).  
ATMCs share phenotypic marker similarities with MCECs 
qPCR analysis 
ATMCs cultured for 2 days in MRPM and P3 MCECs were analyzed by qPCR for 
11 
 
their expression of several corneal endothelium markers (Fig. 3). Collagen alpha-2 IV and 
VII chains (COL4A2 and COL8A2, respectively), solute carrier family 4 (anion exchanger), 
member 4 (SLC4A4), carbonic anhydrase II (CAR2), Na+/K+-ATPase subunit alpha-1 
(ATP1A1) and N-cadherin (CDH2) were expressed in significantly higher extent in the 
stripped corneal endothelium than in whole corneas.  
Interestingly, COL4A2 and N-cadherin genes were found to be expressed many 
times higher in P3 MCECs than in the stripped corneal endothelium (freshly isolated 
MCECs), evidencing thus phenotypic changes undertaken by MCECs upon culture. In this 
way, COL8A2 and CAR2 genes were in contrast strongly down-regulated in P3 MCECs as 
compared with freshly isolated MCECs, confirming hence a partial loss of the CECs 
phenotype upon subculture.  
Relevantly, we found that COL4A2, SLC4A4, CAR2 and NA+/K+-ATPase genes 
were expressed at higher levels in freshly isolated ATMCs than in the stripped corneal 
endothelium, suggesting hence that the mesothelium tissue share phenotypic and 
functional similarities with the corneal endothelium. COL8A2, a highly specific corneal 
endothelium marker52 was in contrast expressed to a lower extent in freshly isolated 
ATMCs (P<0.03). As previously found for cultured MCECs, COL4A2 and N-cadherin genes 
were also strongly up-expressed in the MRPM cultured ATMCs (P<0.03 for both genes), 
suggesting hence phenotypic changes suffered by ATMCs in response to culture 
conditions. Despite this, the expression of the corneal endothelium genes COL8A2, 
SLC4A4, CAR2 and NA+/K+-ATPase was found to be almost similar in the freshly isolated 
and MRPM cultured ATMCs.  
Comparison of the MRPM cultured ATMCs and P3 MCECs indicated that they 
displayed similar expression pattern for COL4A2, COL8A2, SLC4A4 and N-cadherin 
genes. By contrast, NA+/K+-ATPase was however expressed in significantly higher extent 




We next used immunofluorescence procedures to determine the expression pattern 
of corneal endothelium markers in the MRPM cultured ATMCs and P3 MCECs (Fig. 4 and 
Table 1). Positive immunoexpression of COL8A2, N-cadherin, ZO-1, β-catenin, NA+/K+-
ATPase and SLC4A4 could be accordingly detected in the endothelial layer of mouse 
corneas sections and were widely expressed in P3 MCECs (Fig. 4). Of major relevance, 
ATMCs cultured in MRPM were also found to immunoexpress these corneal endothelium 
markers in an extent almost similar to P3 MCECs, indicating hence that ATMCs share 
many phenotypic similarities with MCECs. Furthermore, ATMCs and MCECs display very 
similar surface marker patterns as they displayed no expression for CD31 and CD45, low 
expression for CD44 and high expression for CD29 and CD54 (Table 1). 
Characterization of decellularized HALCs 
HALCs obtained by capsulorhexis were transparent sheets of around 5 millimeters 
diameter and 20µm thickness. Transmission electronic microscope analysis of 
decellularized HALCs could confirm that their decellularization was fully accomplished 
within sterile water (Supplementary Fig. S2).  
Characterization of ATMCs-HALCs composites. 
Microscopic analysis  
Adhesion of ATMCs on top of HALCs was mostly achieved within only 2 hours of 
culture (data not shown). After 24 hours of culture, ATMCs were firmly adhered on top of 
HALCs and a subset of them were actively proliferating as indicated by the presence of 
small round and refringent cells (Fig. 5A). ATMCs gradually reached confluence on top of 
HALCs between 24 and 72 hours of culture in MRPM (Fig. 5B). Noticeably, confluent 
ATMCs lacked α-SMA and F-actin positive stress fibers, indicating hence they did not 
undergo significant EMT (Fig. 5C). Cell density quantification of the 72 hours cultured 
ATMCs-HALCs composites indicated that the monolayer established by ATMCs reached a 
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mean cell density of 1378 ± 187 cells/mm2 (Fig. 5D). By comparison, the native adult 
mouse corneal endothelium displayed a mean cell density of 3188 ± 277 cells/mm2 (Fig. 
5D and Supplementary Fig. S3).  
Ultrastructural analysis  
Ultrastructural analysis of ATMCs-HALCs composites with transmission electron 
microscopy indicated the presence of numerous microvilli on the apical membrane of 
ATMCs (Fig. 6A), structures that are also particularly abundant in CECs29. ATMCs also 
displayed abundant mitochondria (Fig. 6A) and rough endoplasmic reticulum (Fig. 6B), two 
organelles that are also particularly abundant in CECs4. ATMCs also displayed dense-
electron junctional complexes at apicolateral cell-cell contact, a type of structure consistent 
with desmosomes (Fig. 6B). Interestingly, the basal membrane of ATMCs was found to be 
in close contact with the HALCs surface and displayed numerous invaginations (Fig. 6C). 
Other segments of the ATMCs basal membrane were in contrast rather exvaginated, 
thicker and more electron-dense, a type of structure that is consistent with the 
establishment of focal adhesion complexes with the HALCs surface. 
Discussion 
 Stem cells–based tissue engineering of corneal endothelium equivalents holds the 
promise to provide definitive treatments for corneal endothelial disorders. In recent years, 
significant approaches have been carried out to identify suitable scaffolds and source of 
stem cells to bioengineer functional corneal endothelium equivalents. In most cases, the 
different scaffolds proposed were used in combination with primary HCECs14, 15, 17, 18, 20-27, 
53. Alternatively, different studies also reported the generation of CECs-like cells with 
distinct efficiency from corneal stromal cells30 or extraocular stem cells such as neural 
crest cells10, umbilical cord blood stem cells31 and human ESCs32. 
         The use of heterologous HCECs to bioengineer functional corneal endothelium 
equivalents is undoubtedly promising7, but is however strongly limited by the important 
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shortage of suitable donor corneas and the difficulty to achieve their expansion in sufficient 
numbers without loss of original phenotypic properties due to their induction of EMT by 
serum components 54. Finally, and not less important, corneal endothelium equivalents 
build with heterelogous cells are susceptible to immunological rejection, principally in 
patients with highly vascularized corneal beds55.  
In this study we show through marker analysis that ATMCs are phenotypically and 
functionally quite similar to MCECs and may therefore represent a useful cellular surrogate 
to bioengineer autologous non-immunogenic corneal endothelium equivalents. In 
additional support of their therapeutic use, previous studies already reported the 
successful cultivation of human ATMCs isolated from clinical samples of the greater 
omentum44, 45, 56, 57, the largest visceral adipose tissue depot in humans. Of particular 
interest, it was indicated that each square centimeter of human omental tissue can provide 
around one million ATMCs57. On this basis, and given that the adult human corneal 
endothelium is roughly composed by around 300.000 cells58, the surgical isolation through 
laparascopic surgery of reduced pieces of omental tissue should provide sufficient 
numbers of ATMCs to bioengineer several corneal endothelium equivalents. Alternatively, 
the reports that human peritoneal mesothelial cells (HPMCs) can be isolated from 
peritoneal fluids collected by needle aspiration42, 45 also suggest that this minimal invasive 
approach could also be a way to obtain MCs for tissue engineering of corneal endothelium 
equivalents.   
 Our results indicate that the adipose tissue mesothelium and corneal 
endothelium share morphologic and phenotypic similarities. Of particular relevance, the 
high expression of functional corneal endothelium markers such as SLC4A4, CAR2 and 
Na+/K+-ATPase in the freshly isolated ATMCs suggests that the mesothelium share 
functional similarities with the corneal endothelium. In support of this concept, two previous 
reports already indicated that HPMCs display significant Na+/K+-ATPase pump activity49, 
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50, a function that is critically required for the transport of fluids across the mesothelium 
membrane.  
A critical parameter in tissue engineering of corneal endothelium equivalents is the 
maintenance of the density of replacement cells. Herein, we demonstrate that murine 
ATMCs could adhere, proliferate and generate a confluent and compact monolayer of 
polygonal cells firmly attached on top of the HALC basal membrane. Interestingly, previous 
studies already indicated that HALCs represent an excellent substrate for the adhesion, 
growth and viability of primary HCECs59, 60, limbal epithelial stem cells, human trabecular 
meshwork (HTM) cells61, 62. The use of HALC as surrogate of the Descemet´s membrane 
should be strongly supported by the evidence that both structures are smooth and 
transparent basal membranes permeable to water, electrolytes and nutrients from the 
aqueous humor. In addition, the HALC and Descemet´s membrane display quite similar 
thickness and elasticity63, 64.  Furthermore, they are both principally composed by 
deposition of collagen fibers, being the lens capsule mainly composed by collagen type III 
and in less extent by collagen type I65 whereas the Descemet´s membrane is in contrast 
mainly composed by collagen type IV and VIII66-68. Comparative transplantations 
experiments of both HLAC-based or Descemet´s membrane-based corneal endothelium 
substitutes remain however to be performed to evaluate the performance of HALC as 
substrate surrogate of the Descemet´s membrane. 
Conclusion 
 Primary murine ATMCs share morphological and functional similarities with murine 
CECs, suggesting that ATMCs are useful cells to bioengineer non-immunogenic corneal 
endothelium equivalents. ATMCs could adhere and form adhesion structures with the 
HALCs basal membrane. Monolayer structure and density of the ATMCs-HALCs 
composites was better than expected. Further experiments to assess the functionality of 
human ATMCs as substitute of human CECs are under progress. In the future we propose 
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a similar technique described as Descemet Membrane Endothelial Keratoplasty technique 
that provides a fast and high visual rehabilitation69. 
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Figure 1. Efficient recovery of adipose tissue mesothelial cells (ATMCs) by gentle 
trypsinization of the adult mouse visceral adipose tissue. (A) Left photograph shows 
representative aspect of uterine cords and laterally connected adipose fat pads (AT) after 
surgical separation. Middle photograph shows isolated visceral adipose fat pads. Right 
photograph shows the representative aspect of ATMCs released after trypsinization of 
adipose fat pads. ATMCs were mainly detached as small sheets that rapidly adopted a 
“grape-like” aspect after full cellular retraction. (B) Immunofluorescence characterization of 
ATMCs cultured for 48 hours in MRPM (Mesothelial Retaining Phenotype Media). Upper 
left image shows the typical mesothelial cobblestone-like morphology adopted by ATMCs 
cultures after 48 hours in MRPM. ATMCs displayed the typical epithelial intercellular 
expression (arrowhead) of the tight adhesion proteins β-catenin, ZO-1 (Zona Occludens-
1). ATMCs displayed ring-like F-actin staining (arrowhead) and diffuse cytoplasmic 
expression of α-SMA (alpha-smooth muscle actin). ATMCs accordingly lacked 
immunoexpression of the pan-endothelial marker CD31. A significant number of ATMCs 
cultured in MRPM displayed nuclear expression of the proliferative marker Ki-67 
(arrowheads). Nuclei are counterstained in blue with Hoechst 33342. 
 
Figure 2. Isolation and establishment of MCECs cultures. Corneal endothelium 
stripping typically released large fragments of Descemet membrane (A) from which were 
detached large fragment of the corneal endothelium layer during the process of stripping. 
(B). (C) Adherent culture of MCECs clusters generated a compacted monolayer of MCECs 
exhibiting polygonal morphologies (see enlarged spot). (D) Morphology of MCECs at the 
end of their first subculture, with observable large clusters of tightly packaged MCECs. (E, 
F) Show representative aspect of MCECs morphologies at the end of their second and 
22 
 
third subculture steps, respectively. Note how MCECs retained original cobblestone 
morphologies through sequential subculture steps. 
 
Figure 3. Quantitative RT-PCR analysis of corneal endothelium markers. Expression 
profile of COL4A2, COL8A2, SLC4A4, CAR2, Na+/K+-ATPase and N-cadherin genes was 
analyzed in whole corneas, stripped corneal endothelium, passage 3 subcultured MCECs 
(P3 MCECs), freshly isolated ATMCs (do ATMCs) and ATMCs cultured for 2 days into 
MRPM (d2 ATMCs). Stripped corneal endothelium isolated from six mice served as the 
calibrator sample (black bars). Gene expression was normalized against expression levels 
of YWHAZ (housekeeping gene). Results are mean fold change ± SD in mRNA expression 
relative to the calibrator sample (set as 1) calculated from three distinct isolation of 
corneas and three independent isolation and cultures of MCECs and ATMCs. Statistical 
significance (*P<0.05 and **P<0.03) was determined by using Student’s t-test.  
 
Figure 4. Comparative immunofluorescence analysis of corneal endothelium 
markers expression patterns into cultured MCECs and ATMCs. Left panel shows 
representative immunoexpression levels of F-actin and of the corneal endothelium 
markers COL8A2, N-cadherin, ZO-1, β-catenin, Na+/K+-ATPase and SLC4A4 in mouse 
cornea for reference. Middle and right panel shows respective immunoexpression patterns 
obtained in subcultured MCECs (passage 3) and MRPM cultured ATMCs. Nuclei are 
counterstained in blue with Hoechst 33342. 
 
Figure 5. Morphological analysis of ATMCs seeded Human Anterior Lens Capsules. 
(A) Left image shows a 10X phase contrast picture of one ATMCs-seeded-HALC after 24 
hours of culture in MRPM. White arrows point to the border of the HALC. Plastic surface 
with adhered ATMCs (left upper area) is observable as out of focus. Right upper images 
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show enlargement of blue and red spots drawn in left image. Proliferation at this step was 
evidenced by the presence of many duplets of small round and refringent proliferating cells 
(arrowhead). Other cells were in turn more flattened (arrow) and represent mature ATMCs. 
(B) Representative aspect of ATMCs-seeded-HALCs surface after 72 hours of culture. At 
this step HALCs surface was fully recovered by ATMCs that established tight contact 
between together (see arrow in enlarged black square). (C) Double immunofluorescence 
labelling of F-actin and α-SMA in ATMCs-HALCs composites showing ring like staining 
pattern of F-actin and absence of α-SMA positive stress fibers in ATMCs. (D) MetaMorph-
based quantification of cellular density in the adult mouse corneal endothelium and 
ATMCs-HALCs composites. Data are expressed as the mean ± standard deviation of cell 
counts performed from distinct areas (n=12). Statistical significance was determined by 
using Student’s t-test. 
 
Figure 6. Transmission Electron Microscope analysis of ATMCs-HALCs composites. 
(A) Thin transverse section through a ATMCs-HALCs complex. A total number of four 
ATMCs (black arrowheads) can be observed adhered on top of the HALC basal 
membrane side. Right image shows magnification of black spot. Note how ATMCs, like do 
MCECs, display typical apical membrane protrusions or microvilli on their apical surface 
(black arrows) and numerous mitochondria (red stars). (B) Higher magnification allowing 
the visualization of tight contact established between ATMCs. ATMCs typically displayed a 
large rough endoplasmic reticulum (yellow spot). Right image shows an enlargement of 
black spot drawn in left image and allows the visualization of electron-dense tight junction 
complexes at apicolateral intercellular contact between ATMCs (black arrowheads). (C) 
Left image shows representative aspect of ATMCs basal membrane in tight contact with 
HALCs surface. Right image shows an enlargement of black spot drawn in left image and 
allows the visualization of invaginated segments of ATMCs basal membrane (red arrows) 
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and of exvaginated membrane segments that are strongly electron-dense (black 












Adipose tissue mesothelial cells Corneal endothelial cells 
β-catenin ++ ++ 
ZO-1 ++ ++ 
COL8A2 +/++ ++ 
SLC4A4 +/++ + 
Na+/K+-ATPase ++ ++ 
N-cadherin +/++ ++ 







CD45 (LCA) - - 
CD44 (HCAM) + + 
(-): no expression; (+): low expression; (+/++): intermediate expression; (++):high 
expression. 
Abbreviations: COL8A2, Collagen alpha-2(8) chain; ICAM-1, intercellular cell adhesion 
molecule 1; LCA, leukocyte common antigen; PECAM-1, platelet endothelial cell 
adhesion molecule 1; SLC4A4, solute carrier family 4 (anion exchanger), member 4; 
ZO-1, zona occludens 1. 
 
 
